Prostate Cancer Upgrading Reference Set

NCT02189486 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 382

Last updated 2026-01-07

No results posted yet for this study

Summary

Research repository designed to establish prostate cancer upgrading reference set and development of a risk prediction tool. Repository will include clinical information and biologics on a cohort of 240 men, to predict presence of high grade cancer at time of prostatectomy (removal of prostate) among patients with a low grade cancer diagnosis at time of biopsy.

Conditions

Sponsors & Collaborators

  • Emory University

    collaborator OTHER
  • Stanford University

    collaborator OTHER
  • University of California, Irvine

    collaborator OTHER
  • University of Michigan

    collaborator OTHER
  • The Cleveland Clinic

    collaborator OTHER
  • University of Washington

    collaborator OTHER
  • Fred Hutchinson Cancer Center

    collaborator OTHER
  • University of Miami

    collaborator OTHER
  • Johns Hopkins University

    collaborator OTHER
  • M.D. Anderson Cancer Center

    collaborator OTHER
  • Weill Medical College of Cornell University

    collaborator OTHER
  • Icahn School of Medicine at Mount Sinai

    collaborator OTHER
  • Eastern Virginia Medical School

    collaborator OTHER
  • National Cancer Institute (NCI)

    collaborator NIH
  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Principal Investigators

  • Ian M Thompson Jr, MD · University of Texas

Eligibility

Min Age
35 Years
Max Age
99 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2025-06-16
Completion
2025-06-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02189486 on ClinicalTrials.gov